Tempus AI (TEM) Stock Price

Tempus AI Price

NYSE·CLOSED
76.63
​
Market closed

Revenue has compounded at 65.4% per year over the past 6 years to 1.27 B USD. Tempus AI's net margin stands at -19.3%, up from -100.5% several years earlier. Analysts set a median price target of 60.50 USD, implying 21.0% below the current price. Of 23 analysts, 13 rate the stock a buy — an overall Buy consensus.

Tempus AI stock price

Access this data via the Eulerpool API

Tempus AI business model & stock analysis

Tempus AI Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Chicago, Illinois. The company went IPO on 2024-06-14. Tempus AI, Inc. is a technology company. The company provides next generation diagnostics across multiple disease areas, with technology capabilities, harnessing the data and analytics to help personalize medicine. The Company’s product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing, diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. Its AI applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools. Its primary product of AI applications is Next, an AI platform that leverages machine learning to apply an intelligent layer onto routinely generated data to proactively identify and minimize care gaps for oncology and cardiology patients.

Frequently asked questions about Tempus AI

Analysts currently set an average price target of 66.17 USD for the Tempus AI stock (median: 60.50 USD), implying -13.7 % versus the latest price. The consensus is based on 23 analyst ratings.

23 analysts currently rate the Tempus AI stock: 13 recommend buying, 8 holding and 2 selling. For 2026, analysts expect Tempus AI to generate revenue of 1.60 B USD and earnings per share of -0.22 USD.

Converted at the current exchange rate, the Tempus AI share trades at 68.12 EUR (76.63 USD).

The expected revenue of Tempus AI is 1.60 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Tempus AI is -38.51 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Tempus AI is currently -346.73. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Tempus AI stock.

The price-to-sales ratio (P/S) of Tempus AI is currently 8.37. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Tempus AI stock.

The Eulerpool Quality Score for Tempus AI is 3/10.

The ISIN of Tempus AI is US88023B1035. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Tempus AI is TEM. The ticker symbol is used to trade Tempus AI shares on the stock exchange.

Fair ValueTerminal
68.97 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
334,681.32 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website tempus.com
Currency
USD
Initial public offering
Jun 14, 2024
ISIN
US88023B1035
Cusip
88023B103
Market capitalization
13.35 B USDLarge Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee 2026
-346.73
P/Ee 2027
3,029.09
P/Ee 2028
115.77
P/Ee 2029
41.03
P/Ee 2030
61.77
P/Se
8.37
EV/EBIT
—
P/B Ratio
27.18
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-14.16 %
Gross Margin
62.74 %
EBIT Margin
-18.80 %
Net Margin
-19.27 %
EPS (Earnings Per Share)
-1.41 USD
Net Debt / EBIT
-0.13
Debt/Equity
2.52
Last updated Oct 5, 2026, 2:24 PM

Tempus AI Peer Group